Aclaris

Aclaris shares plummet on terminating development of rheumatoid arthritis drug
Aclaris shares plummet on terminating development of rheumatoid arthritis drug
Reuters
Aclaris
Therapeutics
rheumatoid arthritis
clinical trials
zunsemetinib
Flag link:
Aclaris finishes enrolment in atopic dermatitis Phase IIb trial of ATI-1777
Aclaris finishes enrolment in atopic dermatitis Phase IIb trial of ATI-1777
Clinical Trials Arena
Aclaris
ATI-1777
atopic dermatitis
JAK inhibitors
Flag link:
Aclaris MK2 bears fruit
Aclaris MK2 bears fruit
EP Vantage
Aclaris
rheumatoid arthritis
clinical trials
ATI-450
Flag link:
Recent Job Cuts in the Biopharma Industry
Recent Job Cuts in the Biopharma Industry
BioSpace
Tocagen
Sanofi
Amneal
Daiichi Sankyo
Integra Life Sciences
Aclaris
Bayer
Novartis
Illumina
Merck
Roche Molecular Systems
Prometheus Labs
layoffs
Flag link:
Aclaris hammered as hair loss drug flops in PhII, days after FDA took issue with Eskata ads
Aclaris hammered as hair loss drug flops in PhII, days after FDA took issue with Eskata ads
Endpoints
Aclaris
Rigel Pharma
alopecia areata
ATI-502
clinical tirals
Flag link:
Seasoned reps could help Aclaris' Eskata with a pleasantly surprising launch: analyst
Seasoned reps could help Aclaris' Eskata with a pleasantly surprising launch: analyst
Fierce Pharma
drug reps
dermatology
Aclaris
Eskata
drug launches
seborrheic keratoses
Flag link:
Aclaris limps out to a $55M IPO as biotech falters on Wall Street
Aclaris limps out to a $55M IPO as biotech falters on Wall Street
Fierce Biotech
IPOs
Aclaris
Flag link: